| Product Code: ETC095800 | Publication Date: Jun 2021 | Updated Date: Oct 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
In 2024, China continued to heavily rely on imports of erythromycin, with top exporting countries being Italy, Japan, USA, Taiwan, Province of China, and Spain. The market remained highly concentrated with a high Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) for the period 2020-2024 was -5.88%, indicating a decline in import volumes. Furthermore, the growth rate from 2023-2024 was -4.16%, suggesting a continued slowdown in the importation of erythromycin into China.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Erythromycin Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Erythromycin Market Revenues & Volume, 2021 & 2031F |
3.3 China Erythromycin Market - Industry Life Cycle |
3.4 China Erythromycin Market - Porter's Five Forces |
3.5 China Erythromycin Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.6 China Erythromycin Market Revenues & Volume Share, By Therapeutic Indications, 2021 & 2031F |
3.7 China Erythromycin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Erythromycin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increased prevalence of bacterial infections in China |
4.2.2 Growing awareness about the effectiveness of erythromycin in treating various infections |
4.2.3 Rising healthcare expenditure in the country |
4.3 Market Restraints |
4.3.1 Stringent regulations related to antibiotic use in China |
4.3.2 Emergence of antibiotic resistance impacting the efficacy of erythromycin |
4.3.3 Availability of alternative treatment options affecting the demand for erythromycin |
5 China Erythromycin Market Trends |
6 China Erythromycin Market, By Types |
6.1 China Erythromycin Market, By Formulation |
6.1.1 Overview and Analysis |
6.1.2 China Erythromycin Market Revenues & Volume, By Formulation, 2018 - 2027F |
6.1.3 China Erythromycin Market Revenues & Volume, By Gel, 2018 - 2027F |
6.1.4 China Erythromycin Market Revenues & Volume, By Tablet, 2018 - 2027F |
6.1.5 China Erythromycin Market Revenues & Volume, By Topical Solution, 2018 - 2027F |
6.1.6 China Erythromycin Market Revenues & Volume, By Ointment, 2018 - 2027F |
6.1.7 China Erythromycin Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 China Erythromycin Market, By Therapeutic Indications |
6.2.1 Overview and Analysis |
6.2.2 China Erythromycin Market Revenues & Volume, By Respiratory Tract Infections, 2018 - 2027F |
6.2.3 China Erythromycin Market Revenues & Volume, By Eye Infections, 2018 - 2027F |
6.2.4 China Erythromycin Market Revenues & Volume, By Ear Infections, 2018 - 2027F |
6.2.5 China Erythromycin Market Revenues & Volume, By Skin and Soft Tissue Infections, 2018 - 2027F |
6.2.6 China Erythromycin Market Revenues & Volume, By Gastro-intestinal Infections, 2018 - 2027F |
6.2.7 China Erythromycin Market Revenues & Volume, By Others, 2018 - 2027F |
6.3 China Erythromycin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 China Erythromycin Market Revenues & Volume, By Hospital Pharmacies, 2018 - 2027F |
6.3.3 China Erythromycin Market Revenues & Volume, By Retail Pharmacies, 2018 - 2027F |
6.3.4 China Erythromycin Market Revenues & Volume, By Online Pharmacies, 2018 - 2027F |
7 China Erythromycin Market Import-Export Trade Statistics |
7.1 China Erythromycin Market Export to Major Countries |
7.2 China Erythromycin Market Imports from Major Countries |
8 China Erythromycin Market Key Performance Indicators |
8.1 Prescription rates of erythromycin by healthcare providers |
8.2 Number of clinical trials and research studies related to erythromycin in China |
8.3 Patient adherence to erythromycin treatment regimens |
9 China Erythromycin Market - Opportunity Assessment |
9.1 China Erythromycin Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.2 China Erythromycin Market Opportunity Assessment, By Therapeutic Indications, 2021 & 2031F |
9.3 China Erythromycin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Erythromycin Market - Competitive Landscape |
10.1 China Erythromycin Market Revenue Share, By Companies, 2021 |
10.2 China Erythromycin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here